Cytocast is part of Central Europe Deeptech Startup Map

2022-10-17 by Admin

Cytocast is part of Central Europe Deeptech Startup Map

Cytocast has been accepted to be part of the Central Europe Deeptech Startup Map. We are happy to be included in the deep-tech healthcare ecosystem developing technologies and products on the basis of scientific progress and high-tech innovation. 

Deep-tech developments in the healthcare industry have gained momentum, and it has the potential to change healthcare for the better, for example by allowing us to develop highly personalized treatments for individuals. 

To learn more about our company, visit Cytocast‘s website, and if you want to explore the deep tech ecosystem, you should visit Aper Ventures.

Latest News

Best Solution in the Digital Therapy - 4th Digital Summit Award
Best Solution in the Digital Therapy - 4th Digital Summit Award

Last week, we had the pleasure of presenting Cytocast's cutting-edge technology at the 4th Digital Health Summit as the Best Solution in the Digital Therapy category winner.

Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth
Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth

We are thrilled to announce that we have successfully secured our second investment round...

Cytocast at the Hungarian Molecular Life Science Conference 
Cytocast at the Hungarian Molecular Life Science Conference 

Cytocast team recently participated in the Hungarian Molecular Life Science Conference held in Eger. The conference...

Meet us in person at the Bio-IT Expo in Boston
Meet us in person at the Bio-IT Expo in Boston

We are participating in the Best of Show Awards at Bio-IT World Expo in Boston...